← Back
$NKTR All transactions

NEKTAR THERAPEUTICS

A

$ Value

$0

Shares

25,000

Price

$0

Filed

Dec 23

Insider

Name

Zalevsky Jonathan

Title

Chief R&D Officer

CIK

0001789857

Roles

Officer

Transaction Details

Transaction Date

2025-12-22

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,000

Footnotes

Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs vest over four years from the date of grant (December 22, 2025) in substantially equal quarterly installments based on continued service. | Stock options vest over four years from the date of grant, (December 22, 2025) in substantially equal monthly installments based on continued service.

Filing Info

Accession No.

0001193125-25-331189

Form Type

4

Issuer CIK

0000906709

Zalevsky Jonathan's History

Date Ticker Type Value
2026-02-18 NKTR $13K
2026-01-20 NKTR $138K
2025-12-22 NKTR A $0
2025-12-22 NKTR A $0
2025-11-25 NKTR $63K
2025-11-21 NKTR A $0
2025-11-21 NKTR A $0
2025-09-04 NKTR $26K
2025-09-04 NKTR $15K
2025-09-04 NKTR $7K

Other Insiders at NKTR (90d)

Insider Bought Sold Last
ROBIN HOWARD W
President & CEO
$31K 2026-02-18
Zalevsky Jonathan
Chief R&D Officer
$13K 2026-02-18